Track how companies discuss tariffs and trade policies in their earnings calls, and understand their impact across different industries and regions.
We expect it to remain true no matter what the result of those types of investigations are for medical supplies announced in the late September investigation that's currently underway.
includes over 100 basis points of headwind from tariffs and related FX.
You have not heard us call out any negative impact from tariffs.
We expect to overcome these raw material headwinds and deliver full-year gross margin expansion given both incremental 2026 pricing and accelerated simplification efforts across our supply chain.
We described it about a bit higher than $140 million of tariff cost in 2025 on our last call.
There are lingering questions around tariffs and ongoing geopolitical impacts.
There was a retroactive tariff on one of the pipelines we utilize on the West Coast, and all those charges hit during the fourth quarter.
Early signs suggest that these efforts, together with tariffs on Chinese manufactured goods, are beginning to impact the illicit marketplace.
following a period of tariff-related delays.
we navigated an uncertain economic environment... due to continued tariff volatility and evolving trade pressures